Stock A328130 LUNIT INC.
Add to a list
To use this feature you must be a member
Log inSign up

Lunit Inc. Stock

Equities

A328130

KR7328130000

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
55,000 KRW +7.63% Intraday chart for Lunit Inc. -3.34% -32.84%
May. 24 Lunit to Showcase 7 Studies at Asco 2024, Including Ai Innovations in Her2 Quantification, and Multimodal Predictive Models for Immunotherapy Response CI
May. 23 Lunit Acquires New Zealand's Volpara Health Technologies MT

Financials

Sales 2024 * 53.55B 38.66M Sales 2025 * 96.38B 69.58M Capitalization 1,586B 1.14B
Net income 2024 * -15B -10.83M Net income 2025 * 12B 8.66M EV / Sales 2024 * 26.4 x
Net cash position 2024 * 170B 123M Net cash position 2025 * 180B 130M EV / Sales 2025 * 14.6 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 74.08%
More Fundamentals * Assessed data

Chart Lunit Inc.

Dynamic Chart

Latest news about Lunit Inc.

Lunit to Showcase 7 Studies at Asco 2024, Including Ai Innovations in Her2 Quantification, and Multimodal Predictive Models for Immunotherapy Response CI
Lunit Acquires New Zealand's Volpara Health Technologies MT
Lunit Inc. completed the acquisition of Volpara Health Technologies Limited from Harbour Asset Management Limited and others. CI
Volpara to Delist After Court Approves Acquisition by Lunit MT
Lunit Wins Shareholder Approval for Volpara Health Takeover MT
Volpara Health Technologies Secures Approval for Lunit’s Proposed Takeover MT
Lunit's AI Demonstrates Up to 70% Workload Reduction and Enhanced Accuracy in Breast Cancer Screening: Study in European Radiology Reveals CI
Lunit Announces Publication of New Study Featuring Lunit SCOPE IO CI
Lunit Announces Two Commercial Deals Signal its Expansion in Europe CI
Lunit Inc. Receives Two Supply Contracts That Mark Its Strategic Expansion into the East and Southeast Asian Region CI
Lunit Announces Three-Year Supply Contract with Samsung Electronics CI
GC Cell Signs Agreement with Lunit for AI-Powered Cancer Treatment MT
Lunit to Take Over Volpara Health; Lunit Shares Decline 4% MT
Lunit Inc. agreed to acquire Volpara Health Technologies Limited from Harbour Asset Management Limited and others for AUD 300 million. CI
Lunit Inc. Partners with NTT DATA Singapore to Introduce Lunit Insight CXR to Singapore's Public Healthcare System CI
More news

Press releases Lunit Inc.

Lunit SCOPE IO Reveals Promising Results in Neoadjuvant Immunotherapy Study for Head and Neck Cancer Patients AQ
Lunit SCOPE AI Enhances Pathologist Concordance and Accuracy in HER2, ER, and PR Assessment, New Study in Breast Cancer Research AQ
Lunit Presents Seven Study Results at ECR 2024, Showcasing AI's Robust Performance in Diverse Clinical Settings AQ
New Study Demonstrates Predictive Value of Lunit SCOPE IO to Predict Outcomes of Immune Checkpoint Inhibitor Therapy across Diverse Tumors, published in the JITC AQ
Lunit INSIGHT CXR Excels in Long Nodule Detection, Exceptional Performance in Head-to-Head Study published in Radiology AQ
More press releases

Quotes and Performance

1 day+7.63%
1 week-3.34%
1 month-2.65%
3 months-9.54%
6 months-42.89%
Current year-32.84%
More quotes

Highs and lows

1 week
49 500.00
Extreme 49500
56 500.00
1 month
49 500.00
Extreme 49500
60 300.00
Current year
47 150.00
Extreme 47150
82 800.00
1 year
46 400.00
Extreme 46400
139 750.00
3 years
9 450.00
Extreme 9450
139 750.00
5 years
9 450.00
Extreme 9450
139 750.00
10 years
9 450.00
Extreme 9450
139 750.00
More quotes

Managers and Directors - Lunit Inc.

Managers TitleAgeSince
Beom-Seok Suh CEO
 Chief Executive Officer 41 15-12-31
Jung-Min Lee FOU
 Founder - 13-08-23
Seung-Wook Baek FOU
 Founder 41 13-08-23
Members of the board TitleAgeSince
Garheng Kong BRD
 Director/Board Member 49 21-10-31
Seung-Wook Baek FOU
 Founder 41 13-08-23
Beom-Seok Suh CEO
 Chief Executive Officer 41 15-12-31
More insiders

ETFs positioned on Lunit Inc.

Name Weight AuM 1st Jan change Investor Rating
SIMPLIFY EMERGING MARKETS PLUS DOWNSIDE CONVEXITY ETF - USD ETF Simplify Emerging Markets Plus Downside Convexity ETF - USD
0.01% 4 M€ -4.41% -
More ETFs positioned on Lunit Inc.

Quotes

Date Price Change Volume
24-05-31 55,000 +7.63% 384,963
24-05-30 51,100 +0.39% 228,557
24-05-29 50,900 -3.78% 302,327
24-05-28 52,900 -3.47% 291,877
24-05-27 54,800 -3.69% 292,958

End-of-day quote Korea S.E., May 30, 2024

More quotes

Company Profile

Lunit Inc is a Korea-based company principally engaged in the development and supply of medical software. The Company is principally engaged in the development and supply of medical software such as cancer diagnostic aid solutions, cancer early detection solutions, cancer risk prediction solutions and others through artificial intelligence (AI) technologies.
Sector
Advanced Medical Equipment & Technology
Calendar
2024-08-10 - Q2 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Ratings for Lunit Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
55,000 KRW
Average target price
100,000 KRW
Spread / Average Target
+81.82%
Consensus

Annual profits - Rate of surprise

Company calendar

Sector Medical Software & Technology Services

1st Jan change Capi.
LUNIT INC. Stock Lunit Inc.
-32.84% 1.15B
VEEVA SYSTEMS INC. Stock Veeva Systems Inc.
-9.49% 28.16B
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+25.35% 8.33B
SECTRA AB Stock Sectra AB
+33.25% 4.39B
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-35.85% 2.43B
VERADIGM INC. Stock Veradigm Inc.
-9.44% 1.6B
OMNICELL, INC. Stock Omnicell, Inc.
-13.39% 1.5B
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
+7.80% 964M
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-37.56% 872M
SURGICAL SCIENCE SWEDEN AB Stock Surgical Science Sweden AB
-20.77% 700M
Medical Software & Technology Services
  1. Stock Market
  2. Equities
  3. A328130 Stock